Regular aspirin use may reduce risk for colorectal, other digestive tract cancers

Regular use of aspirin appeared to reduce the risk for several digestive tract cancers, according to results of a meta-analysis published in Annals of Oncology.Researchers observed increased benefit with longer duration of use, and increased doses appeared to further reduce risk for colorectal cancer.“There are about 175,000 deaths from bowel cancer predicted for 2020 in the EU, of which about 100,000 will be in people aged between 50 and 74 [years],” Carlo La Vecchia, MD, professor of epidemiology at University of Milan School of Medicine in Italy, said in a press release. “IfRead More

Share on facebook
Share on twitter
Share on linkedin